Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | AAAS CL E G H | 8086 | 13666 | OMIM:231550 | Achalasia-Addisonianism-Alacrima syndrome | | | | 57 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | ABCD1 CL E G H | 215 | 61 | OMIM:300100 | Adrenoleukodystrophy | | | | 135 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | ABCD1 CL E G H | 215 | 61 | ORPHA:139399 | Adrenomyeloneuropathy | HP:0040283 - Occasional | | | 135 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | ABCD1 CL E G H | 215 | 61 | ORPHA:139396 | X-linked cerebral adrenoleukodystrophy | HP:0040281 - Very frequent | | | 135 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | AIRE CL E G H | 326 | 360 | OMIM:240300 | AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1 | | | | 92 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | AIRE CL E G H | 326 | 360 | ORPHA:3453 | Autoimmune polyendocrinopathy type 1 | HP:0040281 - Very frequent | | | 92 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | | | | 54 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | | | | 184 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:168558 | 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | HP:0040281 - Very frequent | | | 31 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:289548 | Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | HP:0040281 - Very frequent | | | 31 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | CYP11B1 CL E G H | 1584 | 2591 | OMIM:202010 | Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency | | | | 112 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | CYP11B1 CL E G H | 1584 | 2591 | ORPHA:90795 | Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency | | | | 112 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | CYP11B2 CL E G H | 1585 | 2592 | OMIM:203400 | Corticosterone methyloxidase type I deficiency | | | | 73 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | CYP11B2 CL E G H | 1585 | 2592 | ORPHA:556030 | Early-onset familial hypoaldosteronism | | | | 73 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | CYP11B2 CL E G H | 1585 | 2592 | OMIM:610600 | Hypoaldosteronism, congenital, due to CMO II deficiency | | | | 73 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90793 | Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency | HP:0040283 - Occasional | | | 53 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | GATB CL E G H | 5188 | 8849 | OMIM:618838 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41; COXPD41 | | | | | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | GATC CL E G H | 283459 | 25068 | OMIM:618839 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42; COXPD42 | | | | 1 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | GLI3 CL E G H | 2737 | 4319 | ORPHA:672 | Pallister-Hall syndrome | HP:0040283 - Occasional | | | 270 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | GLI3 CL E G H | 2737 | 4319 | OMIM:146510 | Pallister-Hall syndrome | | | | 270 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | HSD11B2 CL E G H | 3291 | 5209 | OMIM:218030 | Apparent mineralocorticoid excess | | | | 14 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | HSD11B2 CL E G H | 3291 | 5209 | ORPHA:320 | Apparent mineralocorticoid excess | | | | 14 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | HSD17B4 CL E G H | 3295 | 5213 | OMIM:261515 | D-bifunctional protein deficiency | | | | 98 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | HSD3B2 CL E G H | 3284 | 5218 | ORPHA:90791 | Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency | | | | 34 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | KANSL1 CL E G H | 284058 | 24565 | ORPHA:363958 | 17q21.31 microdeletion syndrome | HP:0040283 - Occasional | | | 283 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | KANSL1 CL E G H | 284058 | 24565 | ORPHA:363965 | Koolen-De Vries syndrome due to a point mutation | HP:0040283 - Occasional | | | 283 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | MC2R CL E G H | 4158 | 6930 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 94 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | MC2R CL E G H | 4158 | 6930 | OMIM:202200 | Glucocorticoid deficiency 1 | | | | 94 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | MRAP CL E G H | 56246 | 1304 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 26 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | MRAP CL E G H | 56246 | 1304 | OMIM:607398 | Glucocorticoid deficiency 2 | | | | 26 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | MRPS7 CL E G H | 51081 | 14499 | OMIM:617872 | Combined oxidative phosphorylation deficiency 34 | . | | | 12 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | | | | 220 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:293978 | Deficiency in anterior pituitary function-variable immunodeficiency syndrome | | | | 11 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | NNT CL E G H | 23530 | 7863 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 13 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | NR0B1 CL E G H | 190 | 7960 | OMIM:300200 | Adrenal hypoplasia, congenital | . | | | 48 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:786 | Generalized glucocorticoid resistance syndrome | | | | 79 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | NR3C2 CL E G H | 4306 | 7979 | OMIM:605115 | Hypertension, early-onset, autosomal dominant, with severe exacerbationin pregnancy | | | | 109 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PCSK1 CL E G H | 5122 | 8743 | OMIM:600955 | Proprotein convertase 1/3 deficiency | | | | 65 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | | | | 9 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX1 CL E G H | 5189 | 8850 | ORPHA:44 | Neonatal adrenoleukodystrophy | HP:0040281 - Very frequent | | | 169 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX1 CL E G H | 5189 | 8850 | ORPHA:912 | Zellweger syndrome | HP:0040283 - Occasional | | | 169 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX10 CL E G H | 5192 | 8851 | ORPHA:44 | Neonatal adrenoleukodystrophy | HP:0040281 - Very frequent | | | 75 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX10 CL E G H | 5192 | 8851 | ORPHA:912 | Zellweger syndrome | HP:0040283 - Occasional | | | 75 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX11B CL E G H | 8799 | 8853 | ORPHA:44 | Neonatal adrenoleukodystrophy | HP:0040281 - Very frequent | | | 4 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX11B CL E G H | 8799 | 8853 | ORPHA:912 | Zellweger syndrome | HP:0040283 - Occasional | | | 4 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX12 CL E G H | 5193 | 8854 | ORPHA:44 | Neonatal adrenoleukodystrophy | HP:0040281 - Very frequent | | | 65 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX12 CL E G H | 5193 | 8854 | ORPHA:912 | Zellweger syndrome | HP:0040283 - Occasional | | | 65 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX13 CL E G H | 5194 | 8855 | ORPHA:44 | Neonatal adrenoleukodystrophy | HP:0040281 - Very frequent | | | 66 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX13 CL E G H | 5194 | 8855 | ORPHA:912 | Zellweger syndrome | HP:0040283 - Occasional | | | 66 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX14 CL E G H | 5195 | 8856 | ORPHA:44 | Neonatal adrenoleukodystrophy | HP:0040281 - Very frequent | | | 46 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX14 CL E G H | 5195 | 8856 | ORPHA:912 | Zellweger syndrome | HP:0040283 - Occasional | | | 46 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX16 CL E G H | 9409 | 8857 | ORPHA:44 | Neonatal adrenoleukodystrophy | HP:0040281 - Very frequent | | | 59 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX16 CL E G H | 9409 | 8857 | ORPHA:912 | Zellweger syndrome | HP:0040283 - Occasional | | | 59 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX19 CL E G H | 5824 | 9713 | ORPHA:44 | Neonatal adrenoleukodystrophy | HP:0040281 - Very frequent | | | 62 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX19 CL E G H | 5824 | 9713 | ORPHA:912 | Zellweger syndrome | HP:0040283 - Occasional | | | 62 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX2 CL E G H | 5828 | 9717 | ORPHA:44 | Neonatal adrenoleukodystrophy | HP:0040281 - Very frequent | | | 82 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX2 CL E G H | 5828 | 9717 | ORPHA:912 | Zellweger syndrome | HP:0040283 - Occasional | | | 82 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX26 CL E G H | 55670 | 22965 | ORPHA:44 | Neonatal adrenoleukodystrophy | HP:0040281 - Very frequent | | | 106 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX26 CL E G H | 55670 | 22965 | ORPHA:912 | Zellweger syndrome | HP:0040283 - Occasional | | | 106 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX3 CL E G H | 8504 | 8858 | ORPHA:44 | Neonatal adrenoleukodystrophy | HP:0040281 - Very frequent | | | 47 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX3 CL E G H | 8504 | 8858 | ORPHA:912 | Zellweger syndrome | HP:0040283 - Occasional | | | 47 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX5 CL E G H | 5830 | 9719 | ORPHA:44 | Neonatal adrenoleukodystrophy | HP:0040281 - Very frequent | | | 99 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX5 CL E G H | 5830 | 9719 | ORPHA:912 | Zellweger syndrome | HP:0040283 - Occasional | | | 99 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX6 CL E G H | 5190 | 8859 | ORPHA:44 | Neonatal adrenoleukodystrophy | HP:0040281 - Very frequent | | | 98 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PEX6 CL E G H | 5190 | 8859 | ORPHA:912 | Zellweger syndrome | HP:0040283 - Occasional | | | 98 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | | | | 162 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | | | | 76 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | QRSL1 CL E G H | 55278 | 21020 | OMIM:618835 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40; COXPD40 | | | | | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | SCNN1B CL E G H | 6338 | 10600 | OMIM:177200 | Liddle syndrome 1 | | | | 61 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | SCNN1G CL E G H | 6340 | 10602 | OMIM:618114 | Liddle syndrome 2 | | | | 57 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | SERPINA6 CL E G H | 866 | 1540 | OMIM:611489 | Corticosteroid-binding globulin deficiency | | | | 4 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | | | | 87 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | | | | 47 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | | | | 22 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | STAR CL E G H | 6770 | 11359 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 45 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | | | | 124 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | TBX19 CL E G H | 9095 | 11596 | OMIM:201400 | Acth deficiency, isolated | | | | 57 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | TBX19 CL E G H | 9095 | 11596 | ORPHA:199296 | Congenital isolated ACTH deficiency | | | | 57 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | TCTN3 CL E G H | 26123 | 24519 | ORPHA:2753 | Orofaciodigital syndrome type 4 | HP:0040283 - Occasional | | | 31 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | | | | 238 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | | | | | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | TXNRD2 CL E G H | 10587 | 18155 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 85 | | |
HP:0008207 | HP:0008207 | Primary adrenal insufficiency | 0 | TXNRD2 CL E G H | 10587 | 18155 | OMIM:617825 | GLUCOCORTICOID DEFICIENCY 5; GCCD5 | | | | 85 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | AAAS CL E G H | 8086 | 13666 | OMIM:231550 | Achalasia-Addisonianism-Alacrima syndrome | . | | | 57 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | AAAS CL E G H | 8086 | 13666 | OMIM:231550 | Achalasia-Addisonianism-Alacrima syndrome | . | | | 57 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | ABCD1 CL E G H | 215 | 61 | ORPHA:139396 | X-linked cerebral adrenoleukodystrophy | HP:0040281 - Very frequent | | | 135 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | AIRE CL E G H | 326 | 360 | OMIM:240300 | AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1 | | | | 92 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | AIRE CL E G H | 326 | 360 | ORPHA:3453 | Autoimmune polyendocrinopathy type 1 | HP:0040281 - Very frequent | | | 92 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 54 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 184 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:168558 | 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | HP:0040281 - Very frequent | | | 31 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:168558 | 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | HP:0040281 - Very frequent | | | 31 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:289548 | Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | HP:0040281 - Very frequent | | | 31 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:289548 | Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | HP:0040281 - Very frequent | | | 31 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | CYP11B1 CL E G H | 1584 | 2591 | OMIM:202010 | Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency | | | | 112 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | CYP11B1 CL E G H | 1584 | 2591 | ORPHA:90795 | Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency | HP:0040281 - Very frequent | | | 112 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | CYP11B2 CL E G H | 1585 | 2592 | OMIM:203400 | Corticosterone methyloxidase type I deficiency | . | | | 73 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | CYP11B2 CL E G H | 1585 | 2592 | ORPHA:556030 | Early-onset familial hypoaldosteronism | HP:0040282 - Frequent | | | 73 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | CYP11B2 CL E G H | 1585 | 2592 | OMIM:610600 | Hypoaldosteronism, congenital, due to CMO II deficiency | | | | 73 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90793 | Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency | HP:0040282 - Frequent | | | 53 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90793 | Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency | HP:0040282 - Frequent | | | 53 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | GATB CL E G H | 5188 | 8849 | OMIM:618838 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41; COXPD41 | | | | | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | GATC CL E G H | 283459 | 25068 | OMIM:618839 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42; COXPD42 | | | | 1 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | GLI3 CL E G H | 2737 | 4319 | OMIM:146510 | Pallister-Hall syndrome | | | | 270 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | HSD11B2 CL E G H | 3291 | 5209 | OMIM:218030 | Apparent mineralocorticoid excess | . | | | 14 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | HSD11B2 CL E G H | 3291 | 5209 | ORPHA:320 | Apparent mineralocorticoid excess | HP:0040282 - Frequent | | | 14 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | HSD3B2 CL E G H | 3284 | 5218 | ORPHA:90791 | Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency | HP:0040282 - Frequent | | | 34 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | HSD3B2 CL E G H | 3284 | 5218 | ORPHA:90791 | Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency | HP:0040282 - Frequent | | | 34 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | MC2R CL E G H | 4158 | 6930 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040280 - Obligate | | | 94 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | MC2R CL E G H | 4158 | 6930 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040283 - Occasional | | | 94 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | MC2R CL E G H | 4158 | 6930 | OMIM:202200 | Glucocorticoid deficiency 1 | . | | | 94 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | MRAP CL E G H | 56246 | 1304 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040283 - Occasional | | | 26 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | MRAP CL E G H | 56246 | 1304 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040280 - Obligate | | | 26 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | MRAP CL E G H | 56246 | 1304 | OMIM:607398 | Glucocorticoid deficiency 2 | . | | | 26 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 220 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:293978 | Deficiency in anterior pituitary function-variable immunodeficiency syndrome | HP:0040281 - Very frequent | | | 11 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | NNT CL E G H | 23530 | 7863 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040283 - Occasional | | | 13 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | NNT CL E G H | 23530 | 7863 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040280 - Obligate | | | 13 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | NR0B1 CL E G H | 190 | 7960 | OMIM:300200 | Adrenal hypoplasia, congenital | . | | | 48 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | NR0B1 CL E G H | 190 | 7960 | OMIM:300200 | Adrenal hypoplasia, congenital | . | | | 48 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:786 | Generalized glucocorticoid resistance syndrome | HP:0040281 - Very frequent | | | 79 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | NR3C2 CL E G H | 4306 | 7979 | OMIM:605115 | Hypertension, early-onset, autosomal dominant, with severe exacerbationin pregnancy | . | | | 109 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | PCSK1 CL E G H | 5122 | 8743 | OMIM:600955 | Proprotein convertase 1/3 deficiency | . | | | 65 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 9 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 162 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | HP:0040282 - Frequent | | | 76 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | QRSL1 CL E G H | 55278 | 21020 | OMIM:618835 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40; COXPD40 | | | | | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | SCNN1B CL E G H | 6338 | 10600 | OMIM:177200 | Liddle syndrome 1 | . | | | 61 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | SCNN1G CL E G H | 6340 | 10602 | OMIM:618114 | Liddle syndrome 2 | | | | 57 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | SERPINA6 CL E G H | 866 | 1540 | OMIM:611489 | Corticosteroid-binding globulin deficiency | | | | 4 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 87 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 47 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 22 | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | STAR CL E G H | 6770 | 11359 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040283 - Occasional | | | 45 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | STAR CL E G H | 6770 | 11359 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040280 - Obligate | | | 45 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 124 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | TBX19 CL E G H | 9095 | 11596 | OMIM:201400 | Acth deficiency, isolated | . | | | 57 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | TBX19 CL E G H | 9095 | 11596 | ORPHA:199296 | Congenital isolated ACTH deficiency | HP:0040280 - Obligate | | | 57 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 238 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | | | |
HP:0008207 | HP:0004319 | Decreased circulating aldosterone level | 1 | TXNRD2 CL E G H | 10587 | 18155 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040283 - Occasional | | | 85 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | TXNRD2 CL E G H | 10587 | 18155 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040280 - Obligate | | | 85 | | |
HP:0008207 | HP:0008163 | Decreased circulating cortisol level | 1 | TXNRD2 CL E G H | 10587 | 18155 | OMIM:617825 | GLUCOCORTICOID DEFICIENCY 5; GCCD5 | | | | 85 | | |